Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ZBIO · NASDAQ · Pharmaceutical Preparations
$23.85−1.19 (−4.75%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Zenas Biopharma (ZBIO) · oqro.io/stocks/ZBIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 5, 2026
Xencor, Inc. cut its ZBIO stake below 5% (1.5%)SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Deerfield Management Company, L.P. no longer reported ZBIO for Q4 2025SourceInsider trade · Traded Feb 7, 2025 · Filed Apr 28, 2025
Director purchased ~$78K of ZBIO shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 19, 2025
CEO purchased ~$167K of ZBIO shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Soros Fund Management no longer reported ZBIO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a reduced position in ZBIO for Q4 2024SourceInsider trade · Traded Dec 4, 2024 · Filed Dec 5, 2024
CEO purchased ~$449K of ZBIO shares in the open marketSourceInsider trade · Traded Dec 3, 2024 · Filed Dec 5, 2024
CEO purchased ~$269K of ZBIO shares in the open marketSourceInsider trade · Traded Nov 18, 2024 · Filed Nov 20, 2024
CEO purchased ~$113K of ZBIO shares in the open marketSourceInsider trade · Traded Nov 19, 2024 · Filed Nov 20, 2024
CEO purchased ~$36K of ZBIO shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Soros Fund Management disclosed a new position in ZBIO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deerfield Management Company, L.P. disclosed a new position in ZBIO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Perceptive Advisors LLC disclosed a new position in ZBIO for Q3 2024Source